Steinschneider A, Freed G, Rhetta-Smith A, Santos V R
American Sudden Infant Death Syndrome Institute, Atlanta, GA 30328.
J Pediatr. 1991 Sep;119(3):411-4. doi: 10.1016/s0022-3476(05)82054-2.
To determine whether the incidence of apnea or bradycardia increased after the first diphtheria-tetanus-pertussis (DTP) immunization in 100 subsequent siblings of victims of sudden infant death syndrome, we examined data obtained from floppy disk recordings attached to apnea-bradycardia monitors for episodes of apnea lasting 15 seconds or longer and episodes of bradycardia lasting 10 seconds or longer. The data were divided into three periods: (1) 10 days before the first DTP immunization was received (pre-DTP period), (2) 10 days immediately after the DTP (DTP period), and (3) 10 days after the DTP period (post-DTP period). Seventeen infants had at least one episode of prolonged apnea or prolonged bradycardia either before or after the 30-day study period (eight before only, eight after only, and one before and after). None of the infants had episodes of apnea lasting 15 seconds or more or bradycardia lasting 10 seconds or more during the pre-DTP or DTP period. One episode of apnea, 16 seconds long, and one episode of bradycardia lasting 11 seconds occurred in the post-DTP period. These results failed to confirm the clinical impression that DTP immunizations are associated with an increased frequency and severity of prolonged apnea. They also place in question the utility of assessing an infant's response to a DTP immunization to determine continued risk of apnea and bradycardia before home monitoring is discontinued.
为了确定在100名婴儿猝死综合征受害者的后续兄弟姐妹中,首次接种白喉-破伤风-百日咳(DTP)疫苗后呼吸暂停或心动过缓的发生率是否增加,我们检查了从连接到呼吸暂停-心动过缓监测仪的软盘记录中获取的数据,以查找持续15秒或更长时间的呼吸暂停发作以及持续10秒或更长时间的心动过缓发作。数据分为三个时期:(1)接受首次DTP疫苗接种前10天(DTP前期),(2)DTP接种后立即的10天(DTP期),以及(3)DTP期之后的10天(DTP后期)。17名婴儿在30天研究期之前或之后至少有一次长时间呼吸暂停或长时间心动过缓发作(仅8例在之前,仅8例在之后,1例在之前和之后)。在DTP前期或DTP期,没有婴儿出现持续15秒或更长时间的呼吸暂停发作或持续10秒或更长时间的心动过缓发作。在DTP后期发生了一次持续16秒的呼吸暂停发作和一次持续11秒的心动过缓发作。这些结果未能证实DTP疫苗接种与长时间呼吸暂停频率和严重程度增加相关的临床印象。它们还对在停止家庭监测之前评估婴儿对DTP疫苗接种的反应以确定呼吸暂停和心动过缓持续风险的效用提出了质疑。